New Natural Eugenol Derivatives as Antiproliferative Agents: Synthesis, Biological Evaluation, and Computational Studies. 2023

Syed Nazreen, and Serag Eldin I Elbehairi, and Azizah M Malebari, and Nuha Alghamdi, and Reem F Alshehri, and Ali A Shati, and Nada M Ali, and Mohammad Y Alfaifi, and Ahmed A Elhenawy, and Mohammad Mahboob Alam
Department of Chemistry, Faculty of Science, Al-Baha University, Al-Baha 65799, Kingdom of Saudi Arabia.

Semisynthetic modifications of natural products have bestowed us with many anticancer drugs. In the present work, a natural product, eugenol, has been modified synthetically to generate new anticancer agents. The final compounds were structurally confirmed by NMR, IR, and mass techniques. From the cytotoxicity results, compound 17 bearing morpholine was found to be the most active cytotoxic agent with IC50 1.71 (MCF-7), 1.84 (SKOV3), and 1.1 μM (PC-3) and a thymidylate synthase (TS) inhibitor with an IC50 of 0.81 μM. Further cellular studies showed that compound 17 could induce apoptosis and arrest the cell cycle at the S phase in PC-3 carcinoma. The docking study strongly favors compound 17 to be a TS inhibitor as it displayed a similar interaction to 5-fluorouracil. The in silico pharmacokinetics and DFT computational studies support the results obtained from docking and biological evaluation and displayed favorable pharmacokinetic profile for a drug to be orally available. Compound 17 was found to be a promising TS inhibitor which could suppress DNA synthesis and consequently DNA damage in prostate cancer cells.

UI MeSH Term Description Entries

Related Publications

Syed Nazreen, and Serag Eldin I Elbehairi, and Azizah M Malebari, and Nuha Alghamdi, and Reem F Alshehri, and Ali A Shati, and Nada M Ali, and Mohammad Y Alfaifi, and Ahmed A Elhenawy, and Mohammad Mahboob Alam
December 2022, International journal of molecular sciences,
Syed Nazreen, and Serag Eldin I Elbehairi, and Azizah M Malebari, and Nuha Alghamdi, and Reem F Alshehri, and Ali A Shati, and Nada M Ali, and Mohammad Y Alfaifi, and Ahmed A Elhenawy, and Mohammad Mahboob Alam
November 2020, Molecules (Basel, Switzerland),
Syed Nazreen, and Serag Eldin I Elbehairi, and Azizah M Malebari, and Nuha Alghamdi, and Reem F Alshehri, and Ali A Shati, and Nada M Ali, and Mohammad Y Alfaifi, and Ahmed A Elhenawy, and Mohammad Mahboob Alam
September 2013, Molecules (Basel, Switzerland),
Syed Nazreen, and Serag Eldin I Elbehairi, and Azizah M Malebari, and Nuha Alghamdi, and Reem F Alshehri, and Ali A Shati, and Nada M Ali, and Mohammad Y Alfaifi, and Ahmed A Elhenawy, and Mohammad Mahboob Alam
November 2022, BMC chemistry,
Syed Nazreen, and Serag Eldin I Elbehairi, and Azizah M Malebari, and Nuha Alghamdi, and Reem F Alshehri, and Ali A Shati, and Nada M Ali, and Mohammad Y Alfaifi, and Ahmed A Elhenawy, and Mohammad Mahboob Alam
September 2016, Steroids,
Syed Nazreen, and Serag Eldin I Elbehairi, and Azizah M Malebari, and Nuha Alghamdi, and Reem F Alshehri, and Ali A Shati, and Nada M Ali, and Mohammad Y Alfaifi, and Ahmed A Elhenawy, and Mohammad Mahboob Alam
May 2018, Chemistry Central journal,
Syed Nazreen, and Serag Eldin I Elbehairi, and Azizah M Malebari, and Nuha Alghamdi, and Reem F Alshehri, and Ali A Shati, and Nada M Ali, and Mohammad Y Alfaifi, and Ahmed A Elhenawy, and Mohammad Mahboob Alam
August 2017, MedChemComm,
Syed Nazreen, and Serag Eldin I Elbehairi, and Azizah M Malebari, and Nuha Alghamdi, and Reem F Alshehri, and Ali A Shati, and Nada M Ali, and Mohammad Y Alfaifi, and Ahmed A Elhenawy, and Mohammad Mahboob Alam
October 2013, European journal of medicinal chemistry,
Syed Nazreen, and Serag Eldin I Elbehairi, and Azizah M Malebari, and Nuha Alghamdi, and Reem F Alshehri, and Ali A Shati, and Nada M Ali, and Mohammad Y Alfaifi, and Ahmed A Elhenawy, and Mohammad Mahboob Alam
April 2020, Future medicinal chemistry,
Syed Nazreen, and Serag Eldin I Elbehairi, and Azizah M Malebari, and Nuha Alghamdi, and Reem F Alshehri, and Ali A Shati, and Nada M Ali, and Mohammad Y Alfaifi, and Ahmed A Elhenawy, and Mohammad Mahboob Alam
March 2019, Molecules (Basel, Switzerland),
Copied contents to your clipboard!